Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms

This publication has 23 references indexed in Scilit:

• ACC/AHA Guidelines for the Clinical Application of Echocardiography
  Circulation, 1997
• Left ventricular volume determination using Albunex
  Journal of the American Society of Echocardiography, 1996
• Intravenous albunex during dobutamine stress echocardiography: Enhanced localization of left ventricular endocardial borders
  American Heart Journal, 1995
• Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases
  Journal of the American College of Cardiology, 1995
• Clinical utility of transthoracic two-dimensional and Doppler echocardiography
  Journal of the American College of Cardiology, 1994
• A letter from America
  Heart, 1994
• Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III albunex multicenter trial
  Journal of the American College of Cardiology, 1993
• Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results
  Journal of the American College of Cardiology, 1990
• Regional left ventricular wall motion assessment: Comparison of two-dimensional echocardiography and radionuclide angiography with contrast angiography in healed myocardial infarction
  The American Journal of Cardiology, 1985
• Echocardiographic-cineangiographic correlation in detecting left ventricular aneurysm: A prospective study of 422 patients
  The American Journal of Cardiology, 1982